RecruitingNCT05985668
Towards Improved Diagnostics for Suspected Platelet Function Disorders
Sponsor
Region Stockholm
Enrollment
140 participants
Start Date
Sep 5, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to improve platelet function testing during bleeding investigations. To this end, the study will evaluate the diagnostic accuracy of novel platelet function tests in patients with confirmed or suspected platelet function disorders. Study participants will be recruited from patients that are referred to or treated at the Coagulation Unit, Karolinska University Hospital, and Pediatric Coagulation Unit, Astrid Lingren Children's Hospital.
Eligibility
Min Age: 12 Months
Inclusion Criteria4
- Known platelet function disorder under follow-up at Karolinska University Hospital (genetic or functional assay)
- High likelihood of platelet function disorder (aberrant screening test with inheritance)
- Family investigation for platelet disorder
- Bleeding investigation at Karolinska University Hospital
Exclusion Criteria8
- Antiplatelet or anticoagulant drugs
- vWF:GPIb below 0.40 IU/mL
- Hematocrit below 0.35 or above 0.50
- Other coagulation disorder
- Antiplatelet or anticoagulant drugs
- vWF:GPIb below 0.40 IU/mL
- Hematocrit below 0.35 or above 0.50
- Other coagulation disorder
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05985668